Form 4: Lam Research Legal Chief Sells Shares After Option Exercise

Lam Research's Chief Legal Officer, Ava Harter, exercised stock options and subsequently sold a portion of her common stock holdings.

Summary

• Ava Harter, Chief Legal Officer of Lam Research Corp (LRCX), reported transactions involving the company's common stock and employee stock options.
• On October 27, 2025, Harter exercised 6,010 employee stock options at an exercise price of $77.039 per share.
• Concurrently, she disposed of a total of 9,010 shares of common stock through two separate sales.
• The first sale involved 3,000 shares at a price of $157.48 per share.
• The second sale involved 6,010 shares at a price of $157.46 per share.
• Following these transactions, Harter's direct beneficial ownership of common stock stands at 56,786.455 shares, which includes shares subject to unvested restricted stock units.
• The net effect of these reported transactions was a decrease of 3,000 shares in her direct beneficial ownership.
• Harter continues to beneficially own 12,020 employee stock options.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving option exercise and subsequent share sales, which is a common occurrence for executives. It does not contain information that significantly alters the company's fundamental outlook or market sentiment, hence a neutral score.

Positives

• The exercise of stock options by a Chief Legal Officer indicates a belief in the underlying value of the company's stock.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating pre-planned sales designed to satisfy affirmative defense conditions against insider trading allegations.

Negatives

• A net reduction of 3,000 shares in the Chief Legal Officer's direct beneficial ownership could be perceived as a slight decrease in insider alignment, although such sales are often for personal financial planning or tax purposes.

Risks

• Intentional misstatements or omissions of facts in SEC filings constitute Federal Criminal Violations under 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Future Outlook

Remaining employee stock options will become exercisable in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027, and are set to expire on August 5, 2031.

Industry Context

This filing details a routine insider transaction by a Chief Legal Officer, which is typically driven by personal financial planning or diversification rather than broader industry trends. Such transactions are common for executives with equity compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: A minor decrease in direct insider ownership (3,000 shares) due to sales, which is a common event for executives managing their equity compensation.
• Regulatory Authorities: The filing demonstrates compliance with Section 16(a) of the Securities Exchange Act of 1934.

Next Steps

• Remaining employee stock options will vest in equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.

Key Dates

Keywords

LAM RESEARCH, LRCX, Form 4, insider trading, stock options, beneficial ownership, Ava Harter, Chief Legal Officer, equity sales, Rule 10b5-1